equity

(NASDAQ:STOK) BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on September 15, 2025, it granted stock options to purchase an aggregate of 135,300 shares of common stock to f

(NASDAQ:VERI) DENVER--(BUSINESS WIRE)--Veritone, Inc. (NASDAQ: VERI), a leader in building human-centered enterprise AI solutions, today announced a proposed underwritten public offering of shares of its common stock. Veritone currently intends to use the net proceeds from the offering for working capital and general corporate purposes including, but not limited to, debt service and repayment of indebtedness. The offering is subject to market and other conditions, and there can be no assurance as to whether

(NASDAQ:AMLX) CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

(NYSE:KGS) THE WOODLANDS, Texas--(BUSINESS WIRE)--Kodiak Gas Services, Inc. (NYSE: KGS) (“Kodiak” or the “Company”) today announced the underwritten public offering (the “Offering”) of 10,000,000 shares of its common stock by Frontier TopCo Partnership, L.P. (the “Selling Stockholder”), an affiliate of the funds known as EQT Infrastructure III and EQT Infrastructure IV. Kodiak will not sell any shares of its common stock in the Offering and will not receive any proceeds from the sale of the shares of its

(NYSE:BK) NEW YORK, Sept. 3, 2025 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced that it priced an underwritten public offering of 500,000 depositary shares, each representing a 1/100th interest in a share of its...

(NYSE:DOLE) DUBLIN--(BUSINESS WIRE)--Dole plc (NYSE: DOLE) (the “Company”), a global leader in fresh produce, announced today the commencement of an underwritten secondary offering of an aggregate of 11,917,263 of the Company’s ordinary shares, par value $0.01 per share (the “Ordinary Shares”), by Castle & Cooke Holdings, Inc. and The Murdock Group, LLC (the “Selling Shareholders”). The Company is not selling any Ordinary Shares in the offering, and the Company will not receive any proceeds from the of

(NASDAQ:ATXS) BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 128,000 shares of Astria’s common stock on September 2, 2025 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were g

(NASDAQ:HLNE) CONSHOHOCKEN, Pa., Sept. 2, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced that it has commenced an underwritten public offering of 528,705 shares of Class A common stock, in the aggregate, to be sold...

(NASDAQ:IMG) BEIJING, Sept. 2, 2025 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technology and marketing to enhance its partners' sales growth and commercial value, today announced that on...

NB Private Equity Partners Limited Total Voting Rights

(NASDAQ:PCLA) TOKYO, Aug. 30, 2025 /PRNewswire/ -- On July 28, 2025, PicoCELA Inc. ("PicoCELA" or the "Company,") (NASDAQ: PCLA), a Tokyo-based provider of enterprise wireless mesh solutions, entered into certain share subscription agreements (the "Share Subscription Agreements") with MCC Venture...

(NASDAQ:GRAL) MENLO PARK, Calif., Aug. 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of...

(VIN) A public limited company (société anonyme) with a share capital of €1,457,166,892.50 Registered office: 1973 boulevard de la Défense - 92000 Nanterre Registration number: 552 037 806 RCS Nanterre www.vinci.com Shareholders relations department: actionnaires@vinci.com ____________________________________

Albion Enterprise VCT PLC

OCTOPUS AIM VCT PLC

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription and allocation have been completed on 20 August 2025.

STOCKHOLM, Aug. 21, 2025 /PRNewswire/ -- The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 8 May 2025 resolved on directed issues of redeemable and convertible class C shares and to authorise the Board of Directors to resolve on the repurchase of all issued class...

STOCKHOLM, Aug. 21, 2025 /PRNewswire/ -- The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 8 May 2025 resolved on directed issues of redeemable and convertible class C shares and to authorise the Board of Directors to resolve on the repurchase of all issued class...

NEEDHAM, Mass.--(BUSINESS WIRE)--SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced the pricing of the previously announced underwritten secondary offering of 5,500,000 ordinary shares of SharkNinja by certain selling shareholders affiliated with CJ Xuning Wang (collectively, the “Selling Shareholders”), the Chairperson of SharkNinja’s board of directors, at a price to the public of $116.00 per ordinary share. The size of the offering reflects an increa

Horizon Bank, announced today that it has launched an underwritten public offering of shares of its common stock.